Do healthcare providers pick their patients? This paper uses patient-level administrative data on skilled nursing facilities in California to estimate a structural model of selective admission practices in the nursing home industry. I exploit within-facility covariation between occupancy and...

The main objective of this paper is to shed some clarity on the applicable criteria for the antitrust analysis of side-deals as part of pharmaceutical patent settlements in the European Union. First, this paper critically discusses and compares the criteria used by the EU Commission and the...

The English version of this text is available at: 'http://ssrn.com/abstract=2481539' http://ssrn.com/abstract=2481539La versión en español de este artículo está disponible en: 'http://ssrn.com/abstract=2439008' http://ssrn.com/abstract=2439008 A versão em português deste artigo está...

La versione italiana di questo documento è disponibile all'indirizzo: 'http://ssrn.com/abstract=2481592' http://ssrn.com/abstract=2481592La versión en español de este artículo está disponible en: 'http://ssrn.com/abstract=2439008' http://ssrn.com/abstract=2439008A versão em português...

The English version of this text is available at: 'http://ssrn.com/abstract=2344231' http://ssrn.com/abstract=2344231La version française de ce texte est disponible à l': 'http://ssrn.com/abstract=2336735' http://ssrn.com/abstract=2336735A versão em português deste texto está disponível...

In this paper, we argue that lower prices for pharmaceuticals can be achieved by fostering a new type of competition in the pharmaceutical industry. Lower drug development costs, and hence prices, can be brought about by abolishing national drug administrations and replacing them with private...

Employment-based health insurance is the Rodney Dangerfield of U.S. health policy: it gets no respect from anyone. Employment-based coverage (quot;EBCquot;) may not get much respect, but it covers roughly 177 million people - and it appears to have considerable staying power - even if the...

Access to healthcare providers remains a salient problem in the United States. One important policy solution would be to relax state scope-of-practice (SOP) laws that inhibit the ability of many healthcare providers, such as nurse practitioners, to deliver care. Some states have changed their...

The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of medication labeling changes on brand pharmaceutical products, and whether and what firms do to respond to increased information regarding the safety and efficacy...